Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang… - European heart …, 2014 - academic.oup.com
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …
被引用次数：456 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang… - European Heart …, 2014 - pdfs.semanticscholar.org
Efficacy and safety of apixaban compared with warfarin according to age for stroke
prevention in atrial fibrillation: observatio Page 1 …

[引用][C] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang… - EUROPEAN HEART …, 2014 - ricerca.unich.it
Efficacy and safety of apixaban compared with warfarin according to age for stroke
prevention in atrial fibrillation: observations from the ARISTOTLE trial IRIS IRIS Home …

[引用][C] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang, R De Caterina… - EUROPEAN HEART …, 2014 - arpi.unipi.it
Efficacy and safety of apixaban compared with warfarin according to age for stroke
prevention in atrial fibrillation: observations from the ARISTOTLE trial IRIS IRIS Home …

[引用][C] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang, R De Caterina… - European Heart …, 2014 - cir.nii.ac.jp
Efficacy and safety of apixaban compared with warfarin according to age for stroke
prevention in atrial fibrillation: observations from the ARISTOTLE trial | CiNii Research CiNii …
[HTML] nih.gov

[HTML][HTML] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang, R De Caterina… - European Heart …, 2014 - ncbi.nlm.nih.gov
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang, R De Caterina… - European Heart …, 2014 - diva-portal.org
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …
[PDF] psu.edu

[PDF][PDF] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang, R De Caterina… - European Heart …, 2014 - Citeseer
Efficacy and safety of apixaban compared with warfarin according to age for stroke
prevention in atrial fibrillation: observatio Page 1 …

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

S Halvorsen, D Atar, H Yang, R De Caterina… - European Heart …, 2014 - europepmc.org
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

S Halvorsen, D Atar, H Yang, R De Caterina, C Erol… - 2014 - pubmed.ncbi.nlm.nih.gov
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …